146 related articles for article (PubMed ID: 28707483)
1. Investigational drugs in development for focal segmental glomerulosclerosis.
Trachtman H
Expert Opin Investig Drugs; 2017 Aug; 26(8):945-952. PubMed ID: 28707483
[TBL] [Abstract][Full Text] [Related]
2. Emerging drugs for treatment of focal segmental glomerulosclerosis.
Trachtman H
Expert Opin Emerg Drugs; 2020 Sep; 25(3):367-375. PubMed ID: 32729368
[TBL] [Abstract][Full Text] [Related]
3. Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis.
Siligato R; Cernaro V; Nardi C; De Gregorio F; Gembillo G; Costantino G; Conti G; Buemi M; Santoro D
Expert Opin Investig Drugs; 2018 Nov; 27(11):839-879. PubMed ID: 30360670
[TBL] [Abstract][Full Text] [Related]
4. Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis.
Kim JS; Han BG; Choi SO; Cha SK
Biomed Res Int; 2016; 2016():1630365. PubMed ID: 27088082
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in Treatments of Primary Focal Segmental Glomerulosclerosis in Children.
Han KH; Kim SH
Biomed Res Int; 2016; 2016():3053706. PubMed ID: 27195285
[TBL] [Abstract][Full Text] [Related]
6. Available and incoming therapies for idiopathic focal and segmental glomerulosclerosis in adults.
Belingheri M; Moroni G; Messa P
J Nephrol; 2018 Feb; 31(1):37-45. PubMed ID: 28470475
[TBL] [Abstract][Full Text] [Related]
7. Novel therapies for FSGS: preclinical and clinical studies.
Malaga-Dieguez L; Bouhassira D; Gipson D; Trachtman H
Adv Chronic Kidney Dis; 2015 Mar; 22(2):e1-6. PubMed ID: 25704355
[TBL] [Abstract][Full Text] [Related]
8. Glomerular podocyte vacuolation in focal segmental glomerulosclerosis.
Yoshikawa N; Ito H; Akamatsu R; Hazikano H; Okada S; Matsuo T
Arch Pathol Lab Med; 1986 May; 110(5):394-8. PubMed ID: 3754422
[TBL] [Abstract][Full Text] [Related]
9. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
[TBL] [Abstract][Full Text] [Related]
10. Focal segmental glomerulosclerosis and renal transplantation.
Crosson JT
Transplant Proc; 2007 Apr; 39(3):737-43. PubMed ID: 17445586
[TBL] [Abstract][Full Text] [Related]
11. Urine neutrophil gelatinase-associated lipocalin and kidney injury in children with focal segmental glomerulosclerosis.
Youssef DM; El-Shal AA
Iran J Kidney Dis; 2012 Sep; 6(5):355-60. PubMed ID: 22976261
[TBL] [Abstract][Full Text] [Related]
12. The treatment of idiopathic focal segmental glomerulosclerosis in adults.
Hogan J; Radhakrishnan J
Adv Chronic Kidney Dis; 2014 Sep; 21(5):434-41. PubMed ID: 25168833
[TBL] [Abstract][Full Text] [Related]
13. Focal segmental glomerulosclerosis after renal transplantation.
Shimizu A; Higo S; Fujita E; Mii A; Kaneko T
Clin Transplant; 2011 Jul; 25 Suppl 23():6-14. PubMed ID: 21623907
[TBL] [Abstract][Full Text] [Related]
14. Focal and segmental glomerulosclerosis: varying biologic mechanisms underlie a final histopathologic end point.
Daskalakis N; Winn MP
Semin Nephrol; 2006 Mar; 26(2):89-94. PubMed ID: 16530601
[TBL] [Abstract][Full Text] [Related]
15. Towards a biological characterization of focal segmental glomerulosclerosis.
Devarajan P; Spitzer A
Am J Kidney Dis; 2002 Mar; 39(3):625-36. PubMed ID: 11877584
[TBL] [Abstract][Full Text] [Related]
16. Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN; Alpers CE; Barratt J; Bieler S; Canetta P; Chae DW; Coppock G; Diva U; Gesualdo L; Heerspink HJL; Inrig JK; Kirsztajn GM; Kohan D; Komers R; Kooienga LA; Lieberman K; Mercer A; Noronha IL; Perkovic V; Radhakrishnan J; Rote W; Rovin B; Tesar V; Trimarchi H; Tumlin J; Wong MG; Trachtman H;
N Engl J Med; 2023 Dec; 389(26):2436-2445. PubMed ID: 37921461
[TBL] [Abstract][Full Text] [Related]
17. Clinical course of primary focal segmental glomerulosclerosis (FSGS) in Turkish children: a report from the Turkish Pediatric Nephrology FSGS Study Group.
Beşbaş N; Ozaltin F; Emre S; Anarat A; Alpay H; Bakkaloğlu A; Baskin E; Buyan N; Dönmez O; Düşünsel R; Ekim M; Göko F; Gür-Güven A; Kavukçu S; Mir S; Sönmez F
Turk J Pediatr; 2010; 52(3):255-61. PubMed ID: 20718182
[TBL] [Abstract][Full Text] [Related]
18. Current and emerging treatments for idiopathic focal and segmental glomerulosclerosis in adults.
Ponticelli C; Graziani G
Expert Rev Clin Immunol; 2013 Mar; 9(3):251-61. PubMed ID: 23445199
[TBL] [Abstract][Full Text] [Related]
19. The long-term results of pediatric patients with primary focal and segmental glomerulosclerosis.
Sozeri B; Mir S; Mutlubas F; Sen S
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):87-92. PubMed ID: 20061699
[TBL] [Abstract][Full Text] [Related]
20. Investigational dopamine antagonists for the treatment of schizophrenia.
Wang SM; Han C; Lee SJ; Jun TY; Patkar AA; Masand PS; Pae CU
Expert Opin Investig Drugs; 2017 Jun; 26(6):687-698. PubMed ID: 28443355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
